BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM
242 results:

  • 1. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
    Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
    Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo.
    Chen X; Luo Z; Hu Z; Sun D; He Y; Lu J; Chen L; Liu S
    Eur J Med Chem; 2024 Feb; 266():116082. PubMed ID: 38232462
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study.
    Zhang W; Chen Z; Sa B
    Eur J Gastroenterol Hepatol; 2024 Jan; 36(1):129-134. PubMed ID: 37994618
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.
    Pedersen MA; Gormsen LC; Jakobsen LH; Eyre TA; Severinsen MT; Baech J; Dann EJ; Knapp A; Sahin D; Vestergaard P; El-Galaly TC; Jensen P
    Br J Haematol; 2024 Apr; 204(4):1271-1278. PubMed ID: 37957542
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Similarities and discrepancies between commercially available bioelectrical impedance analysis system and dual-energy X-ray absorptiometry for body composition assessment in 10-14-year-old children.
    Ohara K; Nakamura H; Kouda K; Fujita Y; Mase T; Momoi K; Nishiyama T
    Sci Rep; 2023 Oct; 13(1):17420. PubMed ID: 37833453
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effects of the major formaldehyde catalyzer ADH5 on phenotypes of fanconi anemia zebrafish model.
    Mu A; Cao Z; Huang D; Hosokawa H; Maegawa S; Takata M
    Mol Biol Rep; 2023 Oct; 50(10):8385-8395. PubMed ID: 37615925
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
    Pant S; Schuler M; Iyer G; Witt O; Doi T; Qin S; Tabernero J; Reardon DA; Massard C; Minchom A; Lugowska I; Carranza O; Arnold D; Gutierrez M; Winter H; Stuyckens K; Crow L; Najmi S; Hammond C; Thomas S; Santiago-Walker A; Triantos S; Sweiti H; Loriot Y;
    Lancet Oncol; 2023 Aug; 24(8):925-935. PubMed ID: 37541273
    [TBL] [Abstract] [Full Text] [Related]  

  • 8.
    Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
    J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
    Bolaños-Meade J; Hamadani M; Wu J; Al Malki MM; Martens MJ; Runaas L; Elmariah H; Rezvani AR; Gooptu M; Larkin KT; Shaffer BC; El Jurdi N; Loren AW; Solh M; Hall AC; Alousi AM; Jamy OH; Perales MA; Yao JM; Applegate K; Bhatt AS; Kean LS; Efebera YA; Reshef R; Clark W; DiFronzo NL; Leifer E; Horowitz MM; Jones RJ; Holtan SG;
    N Engl J Med; 2023 Jun; 388(25):2338-2348. PubMed ID: 37342922
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting.
    Skafida E; Andrikopoulou A; Terpos E; Markellos C; Moustafa S; Pectasides D; Dimopoulos MA; Zagouri F; Vassilopoulos D
    Breast J; 2023; 2023():3614296. PubMed ID: 37293258
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Opioid prescriptions at the point of surgery, bone metastasis, or death among patients with breast cancer in Japanese acute care hospitals: a claims-based, retrospective, longitudinal study.
    Yoshida M; Iwasaki K; Miyashita M; Saeki T; Morioka Y; Hiroi S; Shimizu E
    Support Care Cancer; 2023 Jun; 31(6):369. PubMed ID: 37266722
    [TBL] [Abstract] [Full Text] [Related]  

  • 12.
    Schwenck J; Sonanini D; Seyfried D; Ehrlichmann W; Kienzle G; Reischl G; Krezer P; Wilson I; Korn R; Gonzalez-Menendez I; Quintanilla-Martinez L; Seith F; Forschner A; Eigentler T; Zender L; Röcken M; Pichler BJ; Flatz L; Kneilling M; la Fougere C
    Theranostics; 2023; 13(8):2408-2423. PubMed ID: 37215571
    [No Abstract]    [Full Text] [Related]  

  • 13. Prognostic Significance of Percentage and Size of Dedifferentiation in Dedifferentiated Chondrosarcoma.
    Hung YP; Chebib I; Bredella MA; Berner EA; Taylor-Black Q; Choy E; Cote GM; Chen YL; MacDonald SM; Schwab JH; Raskin KA; Newman ET; Selig MK; Deshpande V; Hornick JL; Lozano-Calderón SA; Nielsen GP
    Mod Pathol; 2023 Mar; 36(3):100069. PubMed ID: 36788104
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy.
    Köksal M; Kersting L; Schoroth F; Garbe S; Koch D; Scafa D; Sarria GR; Leitzen C; Heine A; Holderried T; Brossart P; Zoga E; Attenberger U; Schmeel LC
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5965-5973. PubMed ID: 36607428
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Lack of impact of the aldh2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
    Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
    Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Exploring the Risk Factors of Conjunctival Squamous Cell Carcinoma and Establishing a Prognostic Model: Retrospective Study.
    Xie B; Chen Z; Luo J; Lei Y; Li J; Wu R; Wang Q; Liu X
    Dis Markers; 2022; 2022():5427579. PubMed ID: 36284991
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. FSH-blocking therapeutic for osteoporosis.
    Gera S; Kuo TC; Gumerova AA; Korkmaz F; Sant D; DeMambro V; Sudha K; Padilla A; Prevot G; Munitz J; Teunissen A; van Leent MMT; Post TGJM; Fernandes JC; Netto J; Sultana F; Shelly E; Rojekar S; Kumar P; Cullen L; Chatterjee J; Pallapati A; Miyashita S; Kannangara H; Bhongade M; Sengupta P; Ievleva K; Muradova V; Batista R; Robinson C; Macdonald A; Hutchison S; Saxena M; Meseck M; Caminis J; Iqbal J; New MI; Ryu V; Kim SM; Cao JJ; Zaidi N; Fayad ZA; Lizneva D; Rosen CJ; Yuen T; Zaidi M
    Elife; 2022 Sep; 11():. PubMed ID: 36125123
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature.
    Loeffen YGT; Scharloo F; Goemans BF; Heitink-Polle KMJ; Lindemans CA; van der Bruggen T; Hagen F; Wolfs TFW
    Pediatr Infect Dis J; 2022 Sep; 41(9):e369-e376. PubMed ID: 35703287
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A vitronectin-derived dimeric peptide suppresses osteoclastogenesis by binding to c-Fms and inhibiting M-CSF signaling.
    Jung SY; Min BM
    Exp Cell Res; 2022 Sep; 418(1):113252. PubMed ID: 35697077
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Influence of alcohol sensitivity on bone metastases and skeletal-related events in primary operable breast cancer: A retrospective cohort study.
    Tanda N; Tada H; Washio J; Takahashi N; Ishida T; Koseki T
    PLoS One; 2022; 17(6):e0269335. PubMed ID: 35657923
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.